Zomedica Pharmaceuticals Corp (ZOM) — Long-term Investment Intensity
Zomedica Pharmaceuticals Corp (ZOM) has a Long-term Investment Intensity of 0.5% as of September 2024. Long-term investments of $966.00K represent 0.5% of total assets of $214.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Zomedica Pharmaceuticals Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zomedica Pharmaceuticals Corp Long-term Investment Intensity (2022–2023)
This chart shows how Zomedica Pharmaceuticals Corp's Long-term Investment Intensity has evolved across 2 annual periods from 2022 to 2023. As of September 2024, the intensity stands at 0.5%, reflecting long-term investments of $966.00K against total assets of $214.12 Million USD. Explore Zomedica Pharmaceuticals Corp (ZOM) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Zomedica Pharmaceuticals Corp (2022–2023)
The table below presents the year-by-year Long-term Investment Intensity for Zomedica Pharmaceuticals Corp from 2022 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Zomedica Pharmaceuticals Corp.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 4.0% | $10.01 Million | $253.20 Million | ▼ -10.6 pp |
| 2022 | 14.6% | $40.71 Million | $279.61 Million | — |